German Biotech Days: Trump’s Biotech Dismantling Creates Talent Opportunity for European Life Sciences - Dr. Oliver Schacht

“What we’re witnessing is the rapid dismantling of the US research infrastructure… It’s also an opportunity for us here in Europe to step up” Dr. Oliver Schacht, Managing Director of Life Science Nord

Dr. Oliver Schacht, Managing Director of Life Science Nord and Chairman of the Board for BIO Deutschland, spoke at German Biotechnology Days 2025 (DBT) in Heidelberg about the challenges and opportunities this disruption presents for Germany and the European biotech ecosystem.

In an interview for the PharmaSource podcast, Dr. Schacht explains that in this rapidly evolving landscape, Europe now has a unique opportunity to strengthen its biotech position, fostering a more entrepreneurial research culture, developing strategic partnerships with China, and crafting a forward-looking regulatory framework that supports innovation and competitiveness.

Read the full interview